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Abstract 
BACKGROUND: Respiratory system, together with the cardiovascular and central nervous system, is responsible 
for all processes related to oxygenation and hemodynamics and the defect in the functioning of each of these 
systems, along with ageing, can have mutual effects on their performance and physiological symptoms. The use 
of Pursed-lips Breathing (PLB) training is an essential part of the treatment of patients with the obstructive 
pulmonary disease, PLB stimulates the autonomic nervous system and causes relaxation and improvement of 
physiological parameters. 
AIM: This study was conducted to evaluate the effect of PLB on cardiac, pulmonary and oxygenation level in 
patients with Chronic Obstructive Pulmonary Disease (COPD). 
METHODS: A three-group clinical trial study with experimental and control which was purposefully conducted with 
the participation of patients with COPD and healthy individuals referring to Madani hospital Khoy, in 2017. The 
sample size was selected to be 60 subjects. The patients were randomly allocated to two groups of intervention 
and control with 20 patients, and 20 healthy subjects were assigned to the healthy intervention group. The 
demographic, anthropometric information form and checklist recording changes in levels of oxygenation, 
respiration, temperature, heart rate and blood pressure with cardiopulmonary follow up in three stages before, 
during and after PLB were used for data collection. Data were analysed using descriptive statistics, repeated 
measure test, ANOVA, and Chi-square.  
RESULTS: On evaluation within the COPD patient intervention group in Saturation of Peripheral Oxygen (SPO2) 
index with the mean difference of 2.05 percent, Respiratory Rate(RR)-0.65 minute and Pulse Rate(PR)-1.6 bpm 
was significant (p ≤ 0.05), and systolic blood pressure index in healthy subjects was increased (3.35 mmHg). 
CONCLUSION: The results of this study indicated that using effective PLB as an easy, inexpensive, non- invasive 
and non-pharmacological method is considered as an important factor in improving the status of oxygenation and 
physiological indicators in patients with COPD and should be considered as an important part of rehabilitation 
programs for these patients. 
 
 
 
 
 
Introduction 
 
Chronic illness is a multidimensional health 
challenge with various manifestations and 
disabilities that the patients are in need of long-
term care and education to adapt to their 
physiological changes [1]. COPD is a collection of 
physiological disorders, in which the airflow restriction 
is their most important characteristic. Emphysema and 
chronic bronchitis are included in this complex [2]. 
These diseases cause a wide range of pathological 
changes in the respiratory system, and with a gradual 
decrease in the air flow of exhalation, increasing 
dyspnea, coughing, and confusion [3]. COPD is a 
common progressive, preventable, therapeutic 
disease [4] and spirometry is the most important test 
for the diagnosis and determination the stage of 
disease, where the Forced Expiratory Volume in the 
second first (FEV1) is a good marker for determining 
the severity of the disease and the function of the 
lung.  
According to the results of spirometry, the 
patients are divided into 4 types of mild, moderate, 
severe and very severe [5]. The importance of this 
disease in public health is increasing worldwide, and 
the increasing prevalence of chronic obstructive 
pulmonary disease as one of the priorities of the WHO 
has a significant impact on health care system [6] [7]. 
This illness is the fourth leading cause of death and 
the fifth cause of disability in the United States, and 
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according to Global Initiative for Chronic Obstructive 
Lung Disease (GOLD) estimates, it will move from the 
world's sixth most common cause of death to the 
third rank in 2020. It is estimated that about 64 
million people in the world will get COPD by 2030 
[5].  
To assess signs and predisposing factors, 
consideration of the index of vital signs is the most 
important physiological criteria for assessing 
hemodynamic status [8]. The early prediction of the 
patient's physiological conditions based on vital signs is 
an important and valuable issue, the regular and 
continuous monitoring of it results in proper decisions 
and provision of necessary care to patients [9]. 
Along with vital signs, pulse oximetry as the sixth sign 
of vitality is a standard measure and reliable tool for 
monitoring cardiac and respiratory conditions [10]. 
Lung rehabilitation as part of COPD treatment aimed 
at relieving uncomfortable symptoms, preventing 
cardiovascular and respiratory complications and 
improving quality of life [11].  
In the study conducted by Emtner, Herala, 
Stalenheim [12], results indicated that after the 
implementation of lung rehabilitation programs, the 
clinical status and functional tests of the lung have 
improved in COPD patients. The study conducted by 
Solanes et al., [13] showed the importance of using 
lung rehabilitation programs to increase activity 
tolerance, improving quality of life, and reducing the 
clinical symptoms of COPD. Although breathing 
exercises in the form of pursed-lip breathing may be 
useful to reduce the symptoms of dyspnea and 
improve pulmonary function and quality of life, 
objective evaluation based on pulse oximetry, 
respirogram, and arterial blood gas analysis indicates 
contradictory results and pursed-lip breath exercises 
is not considered as a major component of the lung 
rehabilitation program, because their usefulness is still 
uncertain [14] [15].  
Therefore, the role and efficacy of respiration 
with the pursed lips has remained unclear in the 
rehabilitation of people with COPD. Since all patients 
cannot access the formal and regulated lung 
rehabilitation program, the nurse can play an effective 
role in educating and following-up of a rehabilitation 
program such as self-care, pursed-lips breathing, 
exercise, and energy conservation techniques in daily 
activities [1] [4]. Based on observations and clinical 
experience, nurses do not consider this technique as 
part of a complementary clinical treatment program 
and to improve the health of the patient.  
Studies conducted in Iran regarding the 
lung rehabilitation program, especially the pursed-lip 
breathing, do not appear to be adequate in the field 
of nursing, this study was conducted to evaluate the 
effect of pursed-lips breathing on cardiac, pulmonary 
and oxygenation index in patients with COPD. 
Material and Methods 
 
This study was a  three-group clinical trial, 
randomised controlled and interventional which was 
purposefully conducted with the participation of 
patients with COPD and healthy individuals referring 
to the spirometric unit of Madani hospital Khoy, in 
2017. The content and methods of this study were 
approved by the Ethics Committee of the Deputy of 
Technology and Research of Urmia University of 
Medical Sciences (Approval no. 1395.438).  
Informed written consent was obtained from 
all participants before they took part in the study. 
Participants were informed that they could leave the 
study at any time without penalty, and all personal 
information was kept confidential. The required sample 
size was selected to be 60 subjects based on the 
study conducted by Rossi et al., [16] with α = 0.05, β 
= 0.2, the effect size of 0.17, in the three groups by 
using the G* Power software. Participants were 
randomly allocated to one of two treatment groups: 
posterolateral fusion with pedicle fixation or cognitive 
intervention and exercises. Each eligible patient was 
assigned an identification number by the 
randomisation central at the University of Bergen. The 
concealed random allocation was conducted by a 
computer-generated the random list. Blocks of 10 
patients were used to ensure fairly even-numbered 
treatment groups. 
The samples were selected purposively 
with the participation of 40 COPD patients. 
Participants were randomly allocated in two groups of 
20 subjects: PLB intervention and the control group. 
The control group received just routine cares and 
drug treatments. In PLB intervention group, the 
patients with mild to moderate disease were selected. 
For data gathering, first, demographic and 
anthropometric information was recorded then the 
pulmonary function parameters, vital signs and spo2 
were measured by the Italian SpiroLab MIR Maggiotiro 
125 Spirometric device. The vital signs were measured 
and recorded in three stages, before PLB with rest and 
normal breathing, during PLB and after PLB with 
rest, within 30 minutes in two groups of COPD 
patients and healthy subjects. Recording the 
measurements in the control group was carried out 
in just three 10-minute periods.  
To perform the PLB, the subjects were 
trained to breathe by relaxing the neck and shoulder 
muscles and breathe in the tidal volume range 
through the nose and count up to number 2, then 
close the mouth. In exhalation, she should almost 
press her lips and be constricting the abdominal 
muscles; she should slowly exhale the air in her lungs 
through her mouth by extending the exhalation time 
through the pursed lips counting from 1 to 5. The 
inclusion criteria for the study include the age over 
40, diagnosis of COPD, stability in clinical condition, 
unused rehabilitation programs other than PLB, the 
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absence of underlying chronic illnesses 
(hypertension, cardiomyopathy, or diabetes) and the 
patient's willingness to participate in the study. SPSS 
version 22.0 was used for statistical data analysis. All 
analyses were two-tailed, and the significance level 
was set a 0.05. General characteristics were analysed 
with descriptive statistics. The difference of between 
groups to general characteristics and Cardiac, 
Respiratory, and Oxygenation Indicators were 
analysed with Chi-square and ANOVA or Kruskal 
Wallis. Repeated measure test was used to examine 
the influence of PLB Maneuver on Cardiac, 
Respiratory, and Oxygenation Indicators within 
groups. 
Table 1: Demographic and Anthropometric Characteristics of 
the Studied Groups 
Groups  
Frequency  
Variables 
 Intervention 
(Patient) n% 
Intervention 
(Health) n% 
Control 
(Patient) n% 
P 
Gender Male 9 (45) 7(35) 10 (50) 0.621 
Female 11 (55) 13(65) 10 (50) 
History of 
Smoking 
Yes 14 (70) 20(100) 16 (80) 0.035 
No 6 (30) 0(0) 4 (20) 
History of Drug 
use 
Yes 8 (40) 20(100) 9 (45) 0.001 
No 12 (60) 0(0) 11 (55) 
History of 
Hospitalization 
No 15 (75) 20(100) 17 (85) 0.168 
Once 1 (5) 0(0) 0 (0) 
Twice and more 4 (20) 0(0) 3 (15) 
Groups  
Statistical 
Indicator  
Variables 
Intervention 
(COPD) 
M ± SD 
Intervention 
(Healthy) 
 M ± SD 
Control 
(COPD) 
M ± SD 
F P 
Age (Year)  60.65 ± 12.80 38.80 ± 10.85 61.85 ± 13.38 21.93 0.001 
Duration of 
COPD (Month)  
48.27 ± 52.44 0.0 ± 0.0 205.71 ± 83.84 29.33 0.001 
Weight (Kg)  72.37 ± 17.82 73.35 ± 11.73 73.55 ± 16.50 0.03 0.968 
Height (cm)  159.45 ± 10.90 164.70 ± 10.27 163.95 ± 10.31 1.46 0.240 
BMI (kg/m2)  28.45 ± 7.20 27.36 ± 4.34 27.34 ± 5.65 0.23 0.792 
BSA (m2)  1.75 ± 0.203 1.80 ± 0.17 1.79 ± 0.224 0.32 0.731 
 
 
Results 
 
Based on the pulmonary function indexes, 
the highest mean of Forced Volume Capacity (FVC) 
(4.41 ± 1.31 L), FEV1 (3.39 ± 0.97 L), FEV (70.36 ± 
15.3%), FEV/FVC (85.3 ± 6.8 %) were in the control 
group of healthy subjects (Table 2).  
Table 2: Mean, Standard Deviation and Variance Analysis 
within Group of Pulmonary Function Indexes in Three Group of 
COPD Patients and Healthy Subjects 
Groups  
Statistical 
Indicator  
Variables 
Intervention 
(COPD) 
M ± SD 
Intervention 
(Healthy) 
M ± SD 
Control 
(COPD) 
M ± SD 
F P 
FVC (L)  2.64 ± 1.025 4.41 ± 1.31 3.11 ± 1.35 11.09 0.001 
FEV1 (L)  1.94 ± 0.85 3.39 ± 0.97 2.02 ± 0.94 15.71 0.001 
FEV (%)  65.10 ± 21.92 70.36 ± 15.45 59.98 ± 13.15 1.81 0.173 
FEV/ FVC (%) 
Predicted  
71.57 ± 16.27 85.32 ± 6.89 64.16 ± 13.19 5.37 0.007 
VC (L)  2.79 ± 1.53 3.87 ± 1.43 2.80 ± 1.16 4.01 0.023 
PEF (L/s)  3.52 ± 1.55 6.73 ± 2.18 3.85 ± 2.07 16.27 0.001 
PEF2575 (L/s)  1.70 ± 0.10 3.08 ± 1.095 1.38 ± 0.77 17.57 0.001 
 
Comparing between the groups in the SPO2 
index the highest mean with 96.9 ± 1.2 per cent was 
increased in the healthy group after the intervention of 
the pursed lips breathing. Pulse Rate at the time of 
pursed-lip breathing was decreased than before in 
intervention groups. There was a significant difference 
within groups in the three stages before, during and 
after PLB in comparison with Blood Pressure 
Systole (BPS), Blood Pressure Diastole (BPD) and 
Arterial Mean Pressure (AMP) that were decreased 
in three stages.  
Table 3: Mean, Standard Deviation and Variance Analysis 
between Group of Oxygenation and Cardiopulmonary 
Parameters, Before, During and After PLB in the Studied 
Groups 
Groups  
Statistical Indicator  
Variables 
Intervention (COPD) Intervention 
(Healthy) 
Control (COPD) F P 
SPO2 %  Pre  92.10 ± 3.76 94.05 ± 2.41 91.75 ± 4.98 2.05 0.138 
Inter  94.15 ± 5.23 95.75 ± 1.68 92.5 ± 4.92 2.91 0.043 
Post  93.25 ± 4.81 96.90 ± 1.20 93,05 ± 5.53 5.10 0.009 
RR min  Pre  20.15 ± 1.92 20.45 ± 1.76 21.90 ± 1.71 5.08 0.093 
Inter  19.50 ± 1.87 19.20 ± 1.03 20.85 ± 1.75 3.35 0.042 
Post 19.65 ± 1.53 19.75 ± 1.10 20.60 ± 1.67 7.98 0.001 
T °C  Pre  37.06 ± 0.23 37.13 ± 0.23 37.07 ± 0.16 0.65 0.528 
Inter  36.96 ± 0.18 37.11 ± 0.23 37.08 ± 0.23 2.68 0.077 
Post  36.97 ± 0.16 37.13 ± 0.23 37.08 ± 0.20 3.09 0.053 
PR  
BPM  
Pre  90.75 ± 14.70 84.10 ± 11.23 82.50 ± 12.37 2.32 0.108 
Inter  89.15 ± 14.34 80.55 ± 12.75 80.55 ± 12.13 2.87 0.053 
Post  90.25 ± 15.32 85.35 ± 14.16 84.70 ± 13.47 0.89 0.414 
BPD  
mmHg  
Pre  121.50 ± 12.89 121.50 ± 14.34 134.75 ± 11.18 7.07 0.002 
Inter  119.12 ± 12.70 124.85 ± 14.79 133.65 ± 9.69 6.78 0.002 
Post  117.75 ± 12.62 121.15 ± 12.61 133.07 ± 10.14 9.23 0.001 
BPD  
mmHg  
Pre  78.75 ± 10.87 78.50 ± 13.09 89.75 ± 7.16 7.27 0.002 
Inter  76.50 ± 8.90 78.25 ± 12.28 88.62 ± 6.75 9.35 0.001 
Post  76.75 ± 9.77 77.75 ± 10.94 87.40 ± 7.75 7.62 0.001 
AMP  
mmHg  
Pre  92.99 ± 11.33 92.83 ± 13.38 104.75 ± 7.75 7.62 0.001 
Inter  90.70 ± 9.99 93.78 ± 12.74 103.68 ± 7.44 8.69 0.001 
Post  90.91 ± 9.98 92.21 ± 11.33 102.62 ± 8.07 8.43 0.001 
RPP 
mmHg/min  
Pre  10960.25 ± 2292.15 9771.75 ± 1825.98 10788 ± 1300.15 2.41 0.099 
Inter  10729.40 ± 2155.53 10505.55 ± 1916.30 11014.85 ± 1472.089 0.37 0.690 
Post  10744.50 ± 2445.67 15620.90 ± 27033.66 11241.70 ± 1852.87 0.58 0.561 
Saturation of Peripheral Oxygen (SPO2); Respiratory Rate (RR); Temperature (T); Pulse 
Rate (PR); Blood Pressure Systole (BPS); Blood Pressure Diastole (BPD); Arterial Mean 
Pressure (AMP); Rate Pressure Product (RPP). 
 
In evaluation within COPD patient 
intervention groups with repeated measure test in 
spo2 with a mean difference of 2.05 RR -0.65 and PR 
1.6, there was a significant statistical difference 
(Table 4).  
Table 4: Mean, standard deviation and variance analysis within 
the group of oxygenation and cardiopulmonary parameters, 
before, during and after PLB in the intervention COPD group 
Stage  
Statistical 
Indicator  
Variables 
Pre (PLB) 
M ± SD 
Inter(PLB) 
M ± SD 
Post (PLB) 
M ± SD 
Repeat 
Measure 
P 
SPO2%  92.10 ± 3.77 94.15 ± 5.23 93.25 ± 4.81 F(2) 4.47 0.018 
RR min  20.15 ± 1.92 19.50 ± 1.87 19.65 ± 1.53 F(2) 0.91 0.049 
T °C  37.07 ± 0.23 36.96 ± 0.18 36.97 ± 0.16 F(1.26) 0.28 0.099 
PR bpm  90.75 ± 14.70 89.15 ± 14.34 90.25 ± 15.32 F(2) 0.37 0.054 
BPS mmHg  121.5 ± 12.88 119.12 ± 12.70 117.75 ± 12.61 F(2) 2.36 0.108 
BPD mmHg  78.75 ± 10.87 76.50 ± 8.90 76.75 ± 9.77 F(2) 1.56 0.310 
AMP mmHg  92.99 ± 11.33 90.70 ± 9.99 90.90 ± 9.98 F(1.17) 1.40 0.259 
RPP 
mmHg/min  
10960.25 ± 
2292.15 
10729.40 ± 
2155.35 
10744.50 ± 
2445.67 
F (2) 0.37 0.691 
Saturation of Peripheral Oxygen (SPO2); Respiratory Rate (RR); Pulse Rate (PR); 
Temperature (T); Blood Pressure Systole (BPS); Blood Pressure Diastole (BPD); Arterial 
Mean Pressure (AMP); Rate Pressure Product (RPP). 
 
In the intervention group of healthy 
subjects, there is a significant difference within the 
group in evaluation spo2 1.7, respiratory rate -1.20, 
heart rate 3.55, and systolic blood pressure 3.35 
(Table 5) (p ≤ 0.05). 
 
 
Discussion 
The respiratory system plays a crucial and 
determining role in maintaining and sustaining vital 
human processes. This system, together with the 
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cardiovascular and central nervous system, is 
responsible for all processes related to oxygenation 
and hemodynamics and the defect in the functioning 
of each of these systems, along with ageing, can 
have mutual effects on their performance and 
physiological symptoms [5, 17, 18]. 
Table 5: Mean, Standard Deviation and Variance Analysis 
within Group of Oxygenation and Cardio- Pulmonary 
Parameters, Before, During and After PLB in the Healthy 
Intervention Group 
Stage 
Statistical 
Indicator 
Variables 
Pre (PLB) 
M ± SD 
Inter (PLB) 
M ± SD 
Post (PLB) 
M ± SD 
Repeat 
Measure 
P 
SPO2%  94.05 ± 2.41 95.75 ± 1.68 96.90 ± 1.20 F(2) 6.09 0.001 
RR min  20.45 ± 1.76 19.20 ± 1.03 19.70 ± 1.10 F(2) 0.85 0.342 
T c0  37.135 ± 0.23 37.115 ± 0.23 37.130 ± 0.23 F(2) 677 0.677 
PR bpm  84.10 ± 11.23 80.55 ± 12.75 85.35 ± 14.16 F(2) 3.40 0.044 
BPS mmHg  121.50 ± 14.33 124.85 ± 14.79 121.15 ± 12.61 F(2) 3.47 0.041 
BPD mmHg  78.50 ± 13.09 78.25 ± 12.27 77.75 ± 10.94 F(2) 0.16 0.856 
MAP mmHg  92.83 ± 13.38 93.78 ± 12.74 92.21 ± 11.33 F(2) 0.80 0.458 
RPP 
mmHg/min  
9771.75 ± 
1825.98 
10505.55 ± 
1916.30 
15620.90 ± 
27033.66 
F(1.01) 0.87 0.363 
Saturation of Peripheral Oxygen (SPO2); Respiratory Rate (RR); Pulse Rate (PR); 
Temperature (T); Blood Pressure Systole (BPS); Blood Pressure Diastole (BPD); Arterial 
Mean Pressure (AMP); Rate Pressure Product (RPP). 
 
 
In this study, smoking history in the 
intervention and control group was 30% and 20% 
respectively, and the healthy group did not have a 
history of smoking. In the study conducted by Izadi, 
Afshar, Adib-Hajbaghery [19], 56.3% of COPD 
patients were smokers. In the study of Wade [4], 
cigarette smoking was the main cause of disease 
and quitting was regarded as an essential step in 
controlling COPD. Comparing the mean FVC index in 
the patient intervention group with an average of 2.64 
litres in comparison to the control group (3.11 litres) 
and healthy subjects (4.41 litres), the results were 
indicating a high intensity of shortness of breath in the 
intervention group. In the patient intervention group, 
the mean FEV1 was 65 ± 10%, and FEV1 was 1.94 ± 
0.85 litres, which was matched with the study 
conducted by Ramos (FEV1 60 ± 25%, FEV1 1.53 ± 
0.60 litres) [20]. In the FEV1/FVC index in the COPD 
intervention group with a mean of 71.57 ± 16.27%, 
the severity of the disease was less than the control 
group (64.16 ± 13.19 %) that indicating the presence 
of patients with stable status in this study.  
In the study conducted by Wade [4], before 
pursed-lip breathing, the FEV1 was 2.29 ± 0.58, Peak 
Expiratory Flow (PEF) 459 ± 198, and FVC 3.22 ± 0.53. 
In the Spo2 evaluation, a significant difference was 
observed within the groups, during and after the 
pursed-lip breathing and this improvement was 
observed due to PLB with a proportional increase of 
2.05 per cent in the patient intervention group, healthy 
subjects (1.7%) and control group (0.75%). After 
the intervention and the 10-minute interval of rest, 
recovery was continued in the healthy intervention 
group (1.15%) and control group (0.55%), but in 
the patient intervention group, the patient 
experienced a decrease of (-0.9%), which was 
probably due to fatigue and weakness caused by the 
disease and inability to use of respiratory muscles or 
the immediate effects of the PLB intervention. 
Evaluation in the within groups with repeated 
measure test and follow-up LSD, there was a 
statistically significant difference only before and 
during the pursed-lip breathing, in Spo2 which 
indicates an improvement in the oxygenation state by 
intervention pursed-lip breathing.  
According to the study conducted by 
Solomon [21], a statistically significant difference 
was found with a mean of 1.67 ± 1.35 in the 
pursed-lip intervention group in spo2 improvement. In 
the study conducted by Ramos et al., [20], showed a 
significant increase in SPO2 than before and after 
PLB, which is consistent with the findings of the 
study. The use of PLB training with oxygen therapy is 
an essential part of the treatment of patients with the 
obstructive pulmonary disease, and it is necessary 
whenever arterial oxygen saturation reaches less 
than 90 per cent [1]. There was a significant 
difference in the respiratory rate of the patient 
intervention group and healthy subjects in both 
stages during and after pursed-lip breathing. With 
comparison within-groups in the patient intervention 
group, a decrease of -0.65 and a decrease of -1.25 in 
healthy individuals during the pursed-lip breathing 
was observed in respiratory rate, which indicates a 
decrease in the number of respirations and increases 
in respiration depth by application of PLB technique. In 
the study conducted by Robert et al., [22], it was 
indicated that PLB decreases RR and increase in 
SpO2 and the use of PLB relief to dyspnea, increase 
in self-esteem, and reduced fear especially at night. 
The decrease respiratory rate in the PLB is 
probably due to an increase the Resistance air 
flow during exhalation and the use of muscles 
resulting from increased in tidal volume, improved gas 
exchanges and respiratory sufficiency [23]. In pulse 
rate index, there was a significant difference between 
groups during pursed-lip breathing. With comparing 
within groups, this difference before and during the 
PLB in the intervention group of patients was -1.60 
bpm and -3.55 in the group of healthy subjects, 
which had a significant difference in the stage, before, 
during and after PLB. Therefore, PLB caused a 
decrease in heart rate, and this decrease was higher 
in healthy subjects. This impact is probably due to 
the stimulation of the autonomic nervous system and 
parasympathetic activity [24] [16]. The stimulation of 
vagus nerve causes relaxation and improvement of 
physiological parameters [25].  
Similar to the findings of this study, in the 
study conducted by Solomon [21], heartbeat difference 
was reported in the intervention group of the PLB with 
the Mean and SD (-9.12 ± 6.20). In a study conducted 
by Silva et al. [26] on 18 patients with COPD there 
were no significant correlations between using PLB 
in four activities of walking on the treadmill, wearing 
shoes, lifting cauldron and taking a shower without 
using of PLB in Inspiratory Capacity (IC), SPO2, HR, 
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RR indexes. It seems that in PLB, the exhalation time 
is twice and longer than the inhalation, so it often 
results in a decrease in the heartbeat. In comparison 
between the groups, there was a significant difference 
in systolic, diastolic and mean arterial pressure before, 
during and after PLB, which was mainly due to high 
blood pressure in patients with COPD in the control 
group. In the healthy intervention group, the 
difference (3.35 mmHg) in comparing the systolic 
blood pressure was significant with pursed-lip 
breathing, and PLB resulted in an increase in systolic 
blood pressure, possibly due to the excitement and 
stress caused by spirometric results and stimulating 
the carotid receptors, which leads to an increase in 
systolic blood pressure, after the intervention. In the 
study conducted by Ramos et al., [20], no significant 
changes were observed in BP by doing pursed-lip 
breathing.  
In the study conducted by Maind et al., [27] 
the systolic blood pressure before pursed-lip breathing 
was 144.32 ± 10.80 and after pursed-lip breathing 
149.89 ± 8.08 (P < 0.015) and diastolic blood 
pressure changed from 77.35 ± 5.45 to 77.62 ± 
5.47, respectively that is consistent with this study. 
Variation in BP can be due to changes in the 
chest compression due to respiratory movements, 
which compensate for the increase or decrease in 
systolic blood pressure fluctuations [5] [28]. The 
number and rhythm of respiration not only affects the 
respiratory system but also has direct effects on the 
cardiovascular system. It may be possible to adjust 
the blood pressure and pulse fluctuations and prevent 
cardiovascular complications through breathing PLB 
exercises [29]. The limitations of this study were 
reluctance some of the sampled subjects, especially 
healthy individuals to collaborate in our study, with 
sufficient descriptions of their satisfaction for 
participation. Also, the effects of acute and short-term 
PLB in 30 minutes were evaluated, which may be 
determined in the long-term phase with strengthening 
muscles and respiratory training. Therefore such 
research is recommended to be evaluated over a long 
time span. 
In conclusion, the results of this study 
indicated that the pursed-lip breathing manoeuvre in 
comparison to normal breathing has an improving 
effect on the level of oxygenation. It can lead to 
significant positive changes in respiratory and cardiac 
parameters in COPD patients. Therefore, PLB as an 
easy, inexpensive, non- invasive and non-
pharmacological method is considered as an 
important factor in improving the status of oxygenation 
and physiological indicators in patients with COPD and 
should be considered as an important part of 
rehabilitation programs for these patients. 
Training pursed-lip breathing should be 
considered as nursing standards in nursing care so 
that patients at home can have beneficial effects from 
the PLB whether they are in a family-supported 
program and during follow-up of caregivers. In the 
education program of nursing student's, the 
importance of PLB in lung rehabilitation should be 
considered in teaching the theoretical classes and 
practice with implement nursing process. 
Training pursed-lip breathing should be 
considered as nursing standards in nursing care so 
that patients at home can have beneficial effects from 
the PLB. 
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